Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Operating Expenses | 310 | 330 | 0 | 130 | -1,210 |
| Operating Income | -310 | -330 | N/A | -130 | 1,210 |
| Other Income | 0 | 0 | 0 | 139 | 0 |
| Pre-tax Income | -310 | -330 | 0 | 9 | 1,210 |
| Net Income Continuous | -316 | -336 | -288 | 9 | 1,213 |
| Net Income | $-316 | $-336 | $-288 | $9 | $1,213 |
| EPS Basic Total Ops | -2.00 | -2.00 | -2.00 | 0.00 | 4.00 |
| EPS Basic Continuous Ops | -1.00 | -1.20 | -0.98 | 0.03 | 4.14 |
| EPS Diluted Total Ops | -2.00 | -2.00 | -2.00 | 0.00 | 4.00 |
| EPS Diluted Continuous Ops | -1.00 | -1.20 | -0.98 | 0.03 | 4.14 |
| EBITDA(a) | $-307 | $-327 | $10 | $-139 | $1,210 |